what does a glp-1 do Medications – Community Education Medically Supervised GLP-1 Weight Loss

Your body is encountering a new compound with a new receptor profile, and even though two of the three pathways are familiar, the experience is different

Advances in the science, treatment, and prevention of the disease of obesity: reflections from a diabetes care editors' expert forum

In a combined analysis of subcutaneous (SUSTAIN-6) and oral [PIONEER 6 (NCT02692716)] T2DM CVOTs, semaglutide consistently reduced MACE risk versus placebo across all eGFR and urinary albumin:creatinine ratio (UACR) subgroups [58] Additionally, semaglutide (SELECT) reduced MACE in participants with overweight/obesity and baseline CVD but no T2DM [48]

However, these changes reflect metabolic improvements associated with weight loss rather than any direct effect on the autoimmune process or thyroid gland itself

Step #3

There is no peer-reviewed scientific evidence demonstrating that GLP-1 receptor agonist microdosing is effective or safe